Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. - Scott K. Ziolko; Lisa A. Weissfeld; William E. Klunk; Chester A. Mathis; Jessica A. Hoge; Brian J. Lopresti; Steven DeKosky; Julie C. Price (NeuroImage, 2006)

Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. - Yun Zhou 006; Susan M. Resnick; Weiguo Ye; Hong Fan; Daniel P. Holt; William E. Klunk; Chester A. Mathis; Robert F. Dannals; Dean F. Wong (NeuroImage, 2007)

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. - Alexander Drzezga; Timo Grimmer; Gjermund Henriksen; Isabelle Stangier; Robert Perneczky; Janine Diehl-Schmid; Chester A. Mathis; William E. Klunk; Julie C. Price; Steven DeKosky; Hans-Jürgen Wester; Markus Schwaiger; et al. (NeuroImage, 2008)

Comparative evaluation of template-based region sampling for PiB PET data analysis. - Charles M. Laymon; Bedda L. Rosario; Andrew Redfield; Michael D. Berginc; William E. Klunk; Chester A. Mathis; Julie C. Price (NeuroImage, 2010)

Regular exercise training protects against MPTP-damage to nigrostriatal dopamine neurons in nonhuman primates. - Brian J. Lopresti; Amanda Dettmar; Rehana Leak; Nathan J. Rockcastle; Michael J. Zigmond; Chester A. Mathis; Zhiming Zhang; Judy Cameron (NeuroImage, 2010)

Assessing the threshold for in vivo detection of amyloid-beta plaques. - Chester A. Mathis; William E. Klunk; Eric E. Abrahamson; Ronald L. Hamilton; Julie C. Price; Judith A. Saxton; Oscar L. Lopez; Steven DeKosky; Milos D. Ikonomovic (NeuroImage, 2010)

Further validation of [11C]FLB 457 as a tool to measure prefrontal cortical DA release. - Rajesh Narendran; N. Scott Mason; Eugenii A. Rabiner; Khanum Ridler; Maureen A. May; Chi-Min Chen; Steve Kendro; Chester A. Mathis; Marc Laruelle; W. Gordon Frankle (NeuroImage, 2010)

Statistical modeling of longitudinal PiB retention. - Julie C. Price; Lisa A. Weissfeld; Chester A. Mathis; Bedda L. Rosario; Ann D. Cohen; Judith A. Saxton; Beth Snitz; Michael D. Berginc; Steven DeKosky; William E. Klunk (NeuroImage, 2010)

A multivariate approach for mapping longitudinal changes in amyloid deposition. - Bedda L. Rosario; Lisa A. Weissfeld; Charles M. Laymon; Ann D. Cohen; Jeffrey A. James; William E. Klunk; Chester A. Mathis; Julie C. Price (NeuroImage, 2010)

Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET. - Bedda L. Rosario; Lisa A. Weissfeld; Charles M. Laymon; Chester A. Mathis; William E. Klunk; Michael D. Berginc; Jeffrey A. James; Jessica A. Hoge; Julie C. Price (NeuroImage, 2011)

Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches. - Ann D. Cohen; Wenzhu Mowrey; Lisa A. Weissfeld; Howard Aizenstein; Eric McDade; James M. Mountz; Robert D. Nebes; Judith A. Saxton; Beth Snitz; Steven DeKosky; Jeff Williamson; Oscar L. Lopez; et al. (NeuroImage, 2013)

Statistical Methods for Processing Neuroimaging Data from Two Different Sites with a Down Syndrome Population Application. - Davneet S. Minhas; Zixi Yang; John Muschelli; Charles M. Laymon; Joseph M. Mettenburg; Matthew D. Zammit; Sterling C. Johnson; Chester A. Mathis; Ann D. Cohen; Benjamin L. Handen; William E. Klunk; Ciprian M. Crainiceanu; et al. (IPMU (3), 2020)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome. - Matthew D. Zammit; Dana L. Tudorascu; Charles M. Laymon; Sigan L. Hartley; Shahid H. Zaman; Beau M. Ances; Sterling C. Johnson; Charles K. Stone; Chester A. Mathis; William E. Klunk; Ann D. Cohen; Benjamin L. Handen; et al. (NeuroImage, 2021)